Category: Statement

KELIN Statement on Lenacapavir in Kenya

Lenacapavir, a novel HIV treatment and prevention tool approved by the United States Food and Drug Administration (FDA) represents a significant advancement in the fight

Health CSO statement on Kenya _US STIP

Your REF:  TBA          Our REF:  CSO/STIP/2023/1     Date: 22 February 2023 Alfred K’Ombudo Principal Secretary State Department for Trade Ministry of Investments, Trade, and Industry Kenyatta